BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Razoxane

An antimitotic agent with immunosuppressive properties.

154+ PubMed studies analyzed · 14 RCTs · Evidence Score: 46.9

Research Domains

Razoxane has been studied across 14 research domains including 🔬 Oncology, ✨ Skin & Hair, 😴 Sleep, 🦠 Gut & Microbiome, 🦴 Bone & Joint. The primary research focus is 🔬 Oncology with 66% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Razoxane, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Carmustine
2 shared targets
Furazolidone
2 shared targets
Delavirdine
2 shared targets
iodoform
2 shared targets
Warfarin
2 shared targets
trequinsin
3 shared targets
daph
2 shared targets
Potassium
2 shared targets
Salmeterol
3 shared targets
Phenylbutazone
2 shared targets
Loading evidence profile...

This evidence profile for Razoxane is generated deterministically from 154 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.